Found 0 matching trials
Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years N/A The goal of this \[To evaluate the immunogenicity and safety of 1 - and 2-d...
Show More Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU) PHASE3 This study was designed to evaluate the safety and tolerability of a single...
Show More Location
Achieve Clinical Research, LLC ( Site 0046)
Learn More & Join Trial
Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 PHASE2 This is a randomized, un-blinded, Phase II study in males and non-pregnant ...
Show More Location
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic
Learn More & Join Trial
Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India PHASE3 The aim of the study was to generate immunogenicity and safety data in the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 PHASE4 Subjects will be recruited and divided into 3 groups:
Experimental Group (...
Show More Location
Guangdong Center for Disease Control and Prevention
Learn More & Join Trial
Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17. PHASE3 Multicentric study, Phase III; this study is a randomized, participant- and...
Show More Location
Clinical Research Institute Saltillo
Learn More & Join Trial
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya PHASE2 In 2012, the WHO Strategic Advisory Group of Experts (SAGE) concluded that ...
Show More Location
Siaya District Hospital
Learn More & Join Trial
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age PHASE2 The purpose of this study is to evaluate the immunogenicity and safety of t...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Flucelvax (TIVc or QIVc) Pregnancy Registry N/A The study is a population based prospective cohort study designed to collec...
Show More Learn More & Join Trial
Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children PHASE3 The goal of this clinical trial is to assess tolerability, reactogenicity, ...
Show More Location
State Autonomous Health Care Institution "Engels City Clinical Hospital No1"
Learn More & Join Trial